Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Interleukin 6 and complement serum level study in Parkinson's disease

B. Veselý, M. Dufek, V. Thon, M. Brozman, S. Királová, T. Halászová, E. Koriťáková, I. Rektor,

. 2018 ; 125 (5) : 875-881. [pub] 20180212

Language English Country Austria

Document type Journal Article, Research Support, Non-U.S. Gov't

The objective of this study is to assess whether elevation of serum inflammatory markers levels may indicate the progression of clinical impairment in Parkinson's disease (PD) patients. In 47 PD patients, the serum levels of the C3 and C4 part of the complement and Interleukin-6 (IL-6) were measured. The results at baseline and after 2 years were correlated with scales measuring memory, depression, motor symptoms, and quality of life. Patients with higher levels of C3 and C4 at baseline had decreased quality of life, verbal ability, and memory. Patients with higher IL-6 at baseline showed worse depression scores at 2 years. Patients with persistently higher levels of C3 and C4 at 2 years had worse quality of life and memory ability. Uncorrected p values are reported due to the exploratory nature of the study. The results indicate an impact of inflammation on non-motor signs and quality of life in PD. The increase of levels of serum inflammatory biomarkers may indicate the progression of non-motor impairment in PD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045553
003      
CZ-PrNML
005      
20200115090946.0
007      
ta
008      
200109s2018 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00702-018-1857-5 $2 doi
035    __
$a (PubMed)29435648
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Veselý, Branislav $u Department of Neurology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic. Central European Institute of Technology (CEITEC), Brain and Mind Research Programme, 625 00, Brno, Czech Republic.
245    10
$a Interleukin 6 and complement serum level study in Parkinson's disease / $c B. Veselý, M. Dufek, V. Thon, M. Brozman, S. Királová, T. Halászová, E. Koriťáková, I. Rektor,
520    9_
$a The objective of this study is to assess whether elevation of serum inflammatory markers levels may indicate the progression of clinical impairment in Parkinson's disease (PD) patients. In 47 PD patients, the serum levels of the C3 and C4 part of the complement and Interleukin-6 (IL-6) were measured. The results at baseline and after 2 years were correlated with scales measuring memory, depression, motor symptoms, and quality of life. Patients with higher levels of C3 and C4 at baseline had decreased quality of life, verbal ability, and memory. Patients with higher IL-6 at baseline showed worse depression scores at 2 years. Patients with persistently higher levels of C3 and C4 at 2 years had worse quality of life and memory ability. Uncorrected p values are reported due to the exploratory nature of the study. The results indicate an impact of inflammation on non-motor signs and quality of life in PD. The increase of levels of serum inflammatory biomarkers may indicate the progression of non-motor impairment in PD.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a komplement C3 $x analýza $7 D003176
650    _2
$a komplement 4 $x analýza $7 D003181
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-6 $x krev $7 D015850
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Parkinsonova nemoc $x krev $x imunologie $7 D010300
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dufek, Michal $u Movement Disorders Center, First Department of Neurology, Masaryk University, St. Anne's University Hospital, Pekařská 664/53, 656 91, Brno, Czech Republic.
700    1_
$a Thon, Vojtech $u Department of Clinical Immunology and Allergy, Faculty of Medicine, Masaryk University, St. Anne's University Hospital, 656 91, Brno, Czech Republic.
700    1_
$a Brozman, Miroslav $u Department of Neurology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
700    1_
$a Királová, Silvia $u Department of Clinical Psychology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
700    1_
$a Halászová, Tatiana $u Department of Clinical Psychology, Faculty Hospital, Constantine the Philosopher University, Špitálska 6, 94901, Nitra, Slovak Republic.
700    1_
$a Koriťáková, Eva $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 123/3, 625 00, Brno, Czech Republic.
700    1_
$a Rektor, Ivan $u Movement Disorders Center, First Department of Neurology, Masaryk University, St. Anne's University Hospital, Pekařská 664/53, 656 91, Brno, Czech Republic. irektor@med.muni.cz. Central European Institute of Technology (CEITEC), Brain and Mind Research Programme, 625 00, Brno, Czech Republic. irektor@med.muni.cz.
773    0_
$w MED00010058 $t Journal of neural transmission (Vienna, Austria : 1996) $x 1435-1463 $g Roč. 125, č. 5 (2018), s. 875-881
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29435648 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200115091320 $b ABA008
999    __
$a ok $b bmc $g 1483821 $s 1084226
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 125 $c 5 $d 875-881 $e 20180212 $i 1435-1463 $m Journal of neural transmission $n J Neural Transm $x MED00010058
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...